π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
A Phase 1 study will test the safety, tolerability and pharmacokinetics of ...
Status
Completed
Location
Nucleus Network Limited
Start Date
2016-07-26
Trial ID
NCT03096756
This is a Phase I, single-arm, open-label, prospective, non-randomized, sin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-31
Trial ID
NCT07724106
Treatments Being Tested
Part 1 of the study evaluates the safety and tolerability as well as pharma...
Status
Completed
Location
Quotient Sciences
Start Date
2019-09-12
Trial ID
NCT04514237
Treatments Being Tested
The purpose of this study is to determine whether GSK1521498 attaches to si...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-15
Trial ID
NCT00976066
Treatments Being Tested
The investigators propose a gene therapy strategy using chemical genetic in...
Status
Not Yet Recruiting
Location
Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2025-08-01
Trial ID
NCT07085195
Treatments Being Tested
This is a randomized controlled and assessor-blinded design trial to evalua...
Status
Recruiting
Location
The Third Aο¬liated Hospital of Zhejiang Chinese Medical University
Start Date
2022-03-16
Trial ID
NCT05279963
Treatments Being Tested
This pilot trial aims to study 10 selected commonly prescribed medicines wi...
Status
Completed
Location
Medical University of Vienna, Department of Clinical Pharmacology
Start Date
2022-09-22
Trial ID
NCT06710600